Search

Your search keyword '"Franken NAP"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Franken NAP" Remove constraint Author: "Franken NAP"
41 results on '"Franken NAP"'

Search Results

Catalog

Books, media, physical & digital resources

3. Sensitizing thermochemotherapy with a PARP1-inhibitor

5. Genetic markers of late radiation toxicity in the era of image-guided radiotherapy: lower toxicity rates reduce the predictive value of γ-H2AX foci decay ratio in patients undergoing pelvic radiotherapy.

6. Radiosensitization by Hyperthermia Critically Depends on the Time Interval.

7. Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells.

8. Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin.

9. Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom.

10. Application of HIPEC simulations for optimizing treatment delivery strategies.

11. Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial.

12. A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors.

13. Gamma-H2AX Foci Decay Ratio as a Stronger Predictive Factor of Late Radiation Toxicity Than Dose-Volume Parameters in a Prospective Cohort of Prostate Cancer Patients.

14. Simulating drug penetration during hyperthermic intraperitoneal chemotherapy.

15. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges.

16. PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation.

17. Hyperthermia-Based Anti-Cancer Treatments.

18. Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model.

19. Outcome of a rabbit model for late irradiation effects in mandibular oral mucosa and bone: A pilot study.

20. A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats.

21. HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings.

22. The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.

24. Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines.

25. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer.

26. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer.

28. Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia.

29. Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia.

30. Re‑irradiation plus hyperthermia for recurrent pediatric sarcoma; a simulation study to investigate feasibility.

31. The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose.

32. The clinical benefit of hyperthermia in pancreatic cancer: a systematic review.

33. Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents.

34. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.

35. Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation.

36. Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i.

37. Boosting the effects of hyperthermia-based anticancer treatments by HSP90 inhibition.

38. Targeting therapy-resistant cancer stem cells by hyperthermia.

39. A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer.

40. Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia.

41. 3D radiobiological evaluation of combined radiotherapy and hyperthermia treatments.